HomeKPTI • NASDAQ
add
Karyopharm Therapeutics Inc
Previous close
$5.75
Day range
$5.74 - $5.92
Year range
$3.51 - $12.45
Market cap
98.90M USD
Avg Volume
120.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 44.04M | 13.57% |
Operating expense | 26.61M | -3.71% |
Net income | -33.13M | -3.29% |
Net profit margin | -75.21 | 9.06% |
Earnings per share | -3.82 | 2.05% |
EBITDA | -15.10M | 42.37% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.88M | -65.64% |
Total assets | 96.23M | -49.21% |
Total liabilities | 365.49M | 4.69% |
Total equity | -269.26M | — |
Shares outstanding | 17.05M | — |
Price to book | -0.19 | — |
Return on assets | -37.84% | — |
Return on capital | -294.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -33.13M | -3.29% |
Cash from operations | -5.86M | 69.88% |
Cash from investing | 4.80M | -35.71% |
Cash from financing | 0.00 | — |
Net change in cash | -1.05M | 91.18% |
Free cash flow | -1.97M | 75.16% |
About
Founded
2008
Headquarters
Website
Employees
279
